HR | P | 95% CI | ||
---|---|---|---|---|
Age | 2.46 | 0.04 | 1.04 | 5.84 |
Type II | 0.72 | 0.64 | 0.18 | 1.39 |
CA-125 level (IU/mL) | ||||
< 35 | (Reference) | |||
35–200 | 1.61 | 0.57 | 0.30 | 8.52 |
201–500 | 0.21 | 0.25 | 0.01 | 3.15 |
> 500 | 0.35 | 0.37 | 0.04 | 3.53 |
Ki-67 expression (%) | ||||
< 50 | (Reference) | |||
50–75 | 0.48 | 0.28 | 0.12 | 1.83 |
> 75 | 1.08 | 0.95 | 0.10 | 11.68 |
FIGO Stage | ||||
I | (Reference) | |||
II | 1.45 | 0.66 | 0.27 | 7.74 |
III | 6.45 | 0.03 | 1.25 | 33.40 |
IV | 23.54 | 0.01 | 2.18 | 254.51 |
Maximum diameter (mm) | 0.98 | 0.95 | 0.53 | 1.81 |
Component | ||||
Mixed | (Reference) | |||
Cyst | 2.48 | 0.14 | 0.75 | 8.24 |
Solid | 3.69 | 0.03 | 1.12 | 12.15 |
mean ADC (Log) | 2.24 | 0.25 | 0.56 | 8.95 |
Septa | 0.52 | 0.25 | 0.17 | 1.59 |
High signal on T1WI | 0.98 | 0.96 | 0.39 | 2.47 |